Suppliers / Aveva Drug Delivery Systems

Aveva Drug Delivery Systems

United States 245 employees Updated 9 July 2026

Aveva Drug Delivery Systems is a finished-dose manufacturer based in United States. It appears in 19 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA and Health Canada. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 1 September 2023 as VAI.

0
active US DMFs
0
valid CEPs
2
registered plants 2 with an FDA FEI number
19
filings across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
2 of 2 confirmed
Inspections
6 of 6 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 1 September 2023 VAI US FDA
  • 26 July 2019 NAI US FDA
  • 27 April 2018 VAI US FDA
  • 11 April 2014 VAI US FDA
  • 28 September 2011 VAI US FDA
  • 4 December 2009 OAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Miramar, United States 1000307689
Tamarac, United States 3031136016

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 17 1
Health Canada 2 None

Questions about Aveva Drug Delivery Systems

Does Aveva Drug Delivery Systems hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Aveva Drug Delivery Systems. It does have 19 filings with 2 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Aveva Drug Delivery Systems FDA-registered?
2 sites operated by Aveva Drug Delivery Systems carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Aveva Drug Delivery Systems's last inspection go?
The most recent inspection on record closed on 1 September 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 6 inspections are on file, of which 1 closed as OAI.
Where does Aveva Drug Delivery Systems manufacture?
2 registered sites are on record, in United States (Miramar and Tamarac). Every site is listed on this page with the register it came from.
Which regulators recognise Aveva Drug Delivery Systems's GMP?
Current GMP certificates are on record from US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Aveva Drug Delivery Systems comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 1 September 2023.

Comparable suppliers

Aaa Pharmaceuticals also in United States Aarkish Pharmaceuticals NJ also in United States Abbott Laboratories also in United States Abon Pharmaceuticals also in United States Access Business Group also in United States

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates